Furthermore, we studied the relationship between Topo IIα expression and different factors modifying tumour chemosensitivity, such as Her-2/neu, hormonal receptor, Ki-67 and p53 immunohistochemical detection. The gene discussed is ERBB2; the disease is neoplasm.